Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70073 ↗At a glance
Systematische Übersicht in Phytotherapy Research, 2025. Written by Yonglu Guo and 3 co-authors. Institution: Department of Respiratory and Crical Care Medicine, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China. Major MEDLINE topics: Curcumin, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Cited 3 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY 4.0). Funded by: Heilongjiang Provincial Natural Science Foundation of China, 2021 Central Government's Plan to Support the Talent Training Project of the Reform and Development Fund of Local Universities.
Abstract (original language)
To evaluate the efficacy and explore the potential mechanism of curcumin for the treatment and prevention of NSCLC. We searched six databases thoroughly for articles published before December 2024. Stata 15.0 software was applied for systematic review with meta‐analysis. We utilized network pharmacology, Mendelian randomization, and molecular docking techniques to investigate the pharmacological properties and potential targets of curcumin in the treatment of NSCLC. Twenty‐four studies involving 392 experimental animals were included in this study. Meta‐analysis results showed that curcumin significantly reduced tumor volume of mice ( p < 0.001) in the NSCLC group compared to the control group. Two hundred twenty‐nine curcumin target genes were predicted. 1546 NSCLC‐related genes were obtained by taking the intersection of DEGs and genes in the key module of WGCNA. Eight hub genes were identified by protein–protein interaction. The eight hub genes showed significant clinical value and were found to be negatively correlated with the majority of immune cell infiltration. Molecular docking results indicated a good binding affinity between these eight hub genes and curcumin. Mendelian randomization demonstrated a causal relationship between the AURKB level and the increased risk of NSCLC. In this study, the effectiveness of curcumin has been demonstrated in in vivo models of NSCLC by meta‐analysis. AURKB has been identified as a high‐risk target for NSCLC by network pharmacological analysis and MR for the first time. Our study provides a scientific basis for clinical applications of curcumin in NSCLC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory and Crical Care Medicine, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China.
- College of Medical Technology, Qiqihar Medical University, Qiqihar, China.
- The First Psychiatric Hospital of Harbin, Harbin, China.
- Department of Pharmacy, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China.
ORCID profiles: Ruijun Cai
Funding
- Heilongjiang Provincial Natural Science Foundation of China
- 2021 Central Government's Plan to Support the Talent Training Project of the Reform and Development Fund of Local Universities
Cite
APA
Guo, Y., Xu, H., Shen, P., & Cai, R. (2025). Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization. Phytotherapy Research. https://doi.org/10.1002/ptr.70073
Vancouver
Guo Y, Xu H, Shen P, Cai R. Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization. Phytotherapy Research. 2025. doi:10.1002/ptr.70073
BibTeX
@article{Guo2025,
author = {Guo, Yonglu and Xu, Haohao and Shen, Peng and Cai, Ruijun},
title = {Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70073}
}
EUVIMED